Clinical Trial Update: Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant degarelix with or without apalutamide before radical prostatectomy for prostate cancer; currently listed as ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)
• degarelix (degarelix)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Prostate Cancer, Neoadjuvant Therapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING